Company Overview of Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. discovers and develops anti-inflammatory therapies for respiratory disorders. Its product portfolio comprises FX125L, an orally available small molecule that acts as a broad spectrum chemokine inhibitor (BSCI); FX141L, a back-up compound for FX125L; and FX87L, a BSCI with biopharmaceutical characteristics that make it suitable for topical administration. The company was incorporated in 2005 and is based in Cambridge, the United Kingdom.
Cambridge, CB1 1BH
Founded in 2005
44 1223 451095
Key Executives for Funxional Therapeutics Ltd.
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Funxional Therapeutics Ltd., please visit www.funxionaltherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.